Judging the safety of aprotinin

N Engl J Med. 2006 Nov 23;355(21):2261-2. doi: 10.1056/NEJMc066520.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Advisory Committees
  • Antifibrinolytic Agents / adverse effects*
  • Aprotinin / adverse effects*
  • Cardiac Surgical Procedures
  • Data Interpretation, Statistical
  • Drug Approval*
  • Humans
  • Research Design*
  • United States
  • United States Food and Drug Administration

Substances

  • Antifibrinolytic Agents
  • Aprotinin